Market Update on Financial Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- TGA Approval for Retractable Syringe Manufacturer
- Secures Substantial Aged Care Furniture Order
- Revenue Growth Forecasts
- Preliminary Final Report 30 June 2005
- Enters Letter of Intent with US Corporation
Later from Arovella Therapeutics
- Raises $5 million in Placement
- To Acquire Major Australian Medical Products Distributor
- Bergen Funding
- SUDA granted Canadian Patent for SUD-002
- Business development update
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics